混合恶性卵巢生殖细胞瘤患者的组件模式和生存结果:回顾性队列研究

S Li1, R Zhang1, X Zhang1

  • 1National Clinical Research Center for Obstetric and Gynecologic Diseases, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China.

Clinical oncology (Royal College of Radiologists (Great Britain))
|March 30, 2024
PubMed
概括

这项研究分析了混合恶性卵巢生殖细胞瘤 (mMOGCT) 的组件模式,确定了无复发生存 (RFS) 和疾病特异性生存 (DSS) 的风险因素. 一个新的评分系统将患者分为低风险,中等风险和高风险组,有助于预测结果.